MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Screening of posterior cortical dysfunction in early Parkinson’s disease with mild cognitive impairment as an approach to select patients at higher risk for developing dementia

    H. Bejr-Kasem, J. Pagonabarraga, R. Fernandez-Bobadilla, J. Perez-Perez, J. Marin-Lahoz, B. Pascual-Sedano, S. Martínez-Horta, J. Kulisevsky (Barcelona, Spain)

    Objective: Based on the importance of progressive dysfunction of posterior cortical regions in cognitive deterioration in PD, we explored whether posterior cortical dysfunction in early…
  • 2016 International Congress

    Catechol-o-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson’s disease

    Y. Zhang, Y. Zhang, K. Nie, S. Feng, L. Wang, J. Zhao, Z. Huang, L. Wang (Guangzhou, People's Republic of China)

    Objective: The Catechol-O-Methyltransferase (COMT) Val158Met polymorphism has been proposed to be associated with increased risk of PD and have a specific impact on dopamine-mediated prefrontal…
  • 2016 International Congress

    Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease

    R. Morris, S. Lord, J. Bunce, D. Burn, L. Rochester (Newcastle-Upon-Tyne, United Kingdom)

    Objective: To explore current evidence of associations and predictors of gait and cognition in older adults and pathology to provide a clear understanding of current…
  • 2016 International Congress

    Reliability of verbal and written trail test for individuals with Parkinson’s disease: Is it a good cognitive test?

    M.R. Olchik, M. Ghisi, A. Freiry, A.F.S. Schuh, C.R.M. Rieder (Porto Alegre, Brazil)

    Objective: To verify if the verbal trail test can replace the written trail test, seeing that individuals with PD show considerable motor abnormalities that can…
  • 2016 International Congress

    Association or causation? Orthostatic hypotension and cognitive impairment in α-synucleinopathies: A systematic review

    S.J. Udow, A.E. Lang, M. Masellis (Toronto, ON, Canada)

    Objective: To systematically review the literature for evidence of an association between orthostatic hypotension (OH) and cognitive impairment (CI) in α-synucleinopathies and to discuss possible…
  • 2016 International Congress

    Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia

    R.R. Umarov, N.G. Sokhibnazarov (Tashkent, Uzbekistan)

    Objective: To study the value of various neuropsychological scales to determine the degree of cognitive dysfunction in patients with posttraumatic subcortical Parkinsonian dementia, during the…
  • 2016 International Congress

    The relationship between cognitive aspects (education status, executive function and verbal fluency) and motor aspects (balance and gait) in patients with Parkinson’s disease

    C.O. Souza, M.C. Voos, H.F. Chien, D.V. Francato, A.F. Barbosa, J.M. Greve, E.T. Fonoff, E.R. Barbosa (Sao Paulo, Brazil)

    Objective: The aim of this study was to verify if there would be correlations between cognitive variables (educational status, executive function, verbal fluency) and motor…
  • 2016 International Congress

    Dopaminergic drug management in Parkinson’s disease: Gait and language function show correlation during treatment

    H. Murakami, A. Futamura, T. Kuroda, S. Ishigaki, M. Kezuka, K. Ono, M. Kawamura (Tokyo, Japan)

    Objective: We examined the effects of dopaminergic medication adjustment on cognitive function in Parkinson's disease (PD) patients without apparent dementia (Mini-Mental State Examination score of…
  • 2016 International Congress

    Optic nerve integration as a visuospatial cognitive predictor in Parkinson’s disease

    J.J. Lee, Y. Lee, S.J. Chung, Y.H. Sohn, P.H. Lee (Seoul, Korea)

    Objective: To explore the microstructural integrity of the optic nerve and its role as a cognitive predictor in patients with de novo Parkinson's disease (PD)…
  • 2016 International Congress

    Cerebrospinal fluid biomarkers in Parkinson’s disease and associated cognitive impairment

    M. Delgado-Alvarado, B. Gago, A. Gorostidi, H. Jiménez-Urbieta, J. Ruiz-Martínez, A. Bergaretxe-Yarza, J.F. Martí-Massó, P. Martínez-Lage, A. Izagirre, A. Oregi, L. Sepúlveda, M.C. Rodríguez-Oroz (San Sebastián, Spain)

    Objective: Our aim is to assess CSF levels of amyloid-β1-42 (Aβ1-42), T-Tau, threonine-181 phosphorilated tau (P-Tau) and α-synuclein (α-syn) as well as different ratios of…
  • « Previous Page
  • 1
  • …
  • 1868
  • 1869
  • 1870
  • 1871
  • 1872
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley